|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02538679 |
|
Date of registration:
|
20/08/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques
|
|
Scientific title:
|
A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Technique Versus Laparoscopic Transversus Abdominis Plane Nerve Block Technique Versus No Block on Postoperative Opioid Consumption After Major Colorectal Surgery |
|
Date of first enrolment:
|
August 7, 2015 |
|
Target sample size:
|
127 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02538679 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
|
|
Phase:
|
N/A
|
|
|
Contacts
|
|
Name:
|
Karen Zaghiyan, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Cedars-Sinai Medical Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Willingness and ability to sign an informed consent document
2. No allergies to anesthetic or analgesic medications
3. American Society of Anesthesia (ASA) physical status Class I - III adults of either
sex
4. Aged 18-90 years
Exclusion Criteria:
1. Refusal to participate in the study
2. Age <18 or > 90 years
3. Contraindications to regional blockage including but not limited to:
- Patient refusal to regional blockade
- Infection at the site of needle insertion
- Systemic infection
- Bleeding diathesis or coagulopathy (as diagnosed by history or laboratory
evaluation)
Age minimum:
18 Years
Age maximum:
90 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Postoperative Pain
|
|
Crohn's Disease
|
|
Inflammatory Bowel Disease
|
|
Intervention(s)
|
|
Drug: Lap TAP Bupivacaine/Epinephrine
|
|
Other: Placebo
|
|
Drug: US TAP Bupivacaine/Epinephrine
|
|
Primary Outcome(s)
|
|
Morphine Requirement
[Time Frame: 24 hours]
|
|
Secondary ID(s)
|
|
Pro00037604
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|